EP0603324A1 - Method for preparing the dextrorotatory isomer of an isoindolinone derivative - Google Patents

Method for preparing the dextrorotatory isomer of an isoindolinone derivative

Info

Publication number
EP0603324A1
EP0603324A1 EP92920565A EP92920565A EP0603324A1 EP 0603324 A1 EP0603324 A1 EP 0603324A1 EP 92920565 A EP92920565 A EP 92920565A EP 92920565 A EP92920565 A EP 92920565A EP 0603324 A1 EP0603324 A1 EP 0603324A1
Authority
EP
European Patent Office
Prior art keywords
formula
dextrorotatory isomer
preparing
dextrorotatory
isoindolinone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP92920565A
Other languages
German (de)
French (fr)
Inventor
André Busson
Christophe Daubie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Rhone Poulenc Rorer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer SA filed Critical Rhone Poulenc Rorer SA
Publication of EP0603324A1 publication Critical patent/EP0603324A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Definitions

  • the present invention relates to a process for the preparation of the dextrorotatory isomer of the isoindolinone derivative of formula:
  • the dealkoxycarbonylation of the menthyl ester of formula (II) is carried out by the action of a strong mineral acid at a temperature in the region of 0 ° C. It is particularly advantageous, to obtain a satisfactory enantioselectivity, to use concentrated sulfuric acid.
  • Condensation is generally carried out in an organic solvent in the presence of a base.
  • organic solvent dimethylformamide, racetonitrile, dimethyl sulfoxide, aromatic hydrocarbons (benzene, toluene) or N-methylpyrrolidone are generally used.
  • a base an alkali metal carbonate (sodium, potassium) or a hydride such as sodium hydride is generally used.
  • the reaction is carried out at a temperature between 0 and 50 ° C.
  • the product of formula (IV) can be obtained by chlorination of the product of formula:
  • the product of formula (V) can be obtained according to the method described, for example, in Belgian patent BE 835325.
  • the ⁇ -ketoester of formula (HI) can be obtained according to the method described by

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Procédé de préparation de l'isomère dextrogyre du produit de formule (I) par désalcoxycarbonylation d'un ester de menthyle optiquement actif de formule (II).Process for the preparation of the dextrorotatory isomer of the product of formula (I) by dealkoxycarbonylation of an optically active menthyl ester of formula (II).

Description

PROCEDE DE PREPARATION DR L'ISOMERE DEXTROGYRE D'UN DERIVE DE L'ISOINDOLINONE PROCESS FOR THE PREPARATION OF THE DEXTROGYRE ISOMER OF AN ISOINDOLINONE DERIVATIVE
La présente invention concerne un procédé de préparation de l'isomère dextrogyre du dérivé de l'isoindolinone de formule :The present invention relates to a process for the preparation of the dextrorotatory isomer of the isoindolinone derivative of formula:
qui présente des propriétés anxiolytiques, hypnotiques, anticonvulsivantes, antiépileptiques et myorelaxantes remarquables. which has remarkable anxiolytic, hypnotic, anticonvulsant, antiepileptic and muscle relaxant properties.
Selon le brevet américain US 4 960 779, le produit de formule (I) dextrogyre peut être obtenu à partir du racémique correspondant par chromatographie sur phase chirale. Cependant l'application industrielle de ce procédé n'est pas toujours de réalisation commode.According to American patent US 4,960,779, the product of formula (I) dextrorotatory can be obtained from the corresponding racemic by chromatography on chiral phase. However, the industrial application of this process is not always easy to carry out.
Il a maintenant été trouvé, et c'est ce qui fait l'objet de la présente invention, que l'isomère dextrogyre du produit de formule (I) peut être obtenu par désalcoxycarbonylation d'un ester optiquement actif de formule :It has now been found, and this is the subject of the present invention, that the dextrorotatory isomer of the product of formula (I) can be obtained by dealkoxycarbonylation of an optically active ester of formula:
Généralement, la désalcoxycarbonylation de l'ester de menthyle de formule (II) est effectuée par action d'un acide minéral fort à une température voisine de 0°C. Il est particulièrement avantageux, pour obtenir une énantiosélectivité satisfaisante, d'utiliser l'acide suif urique concentré.Generally, the dealkoxycarbonylation of the menthyl ester of formula (II) is carried out by the action of a strong mineral acid at a temperature in the region of 0 ° C. It is particularly advantageous, to obtain a satisfactory enantioselectivity, to use concentrated sulfuric acid.
L'ester de menthyle de formule (II) peut être obtenu par action du β-cétoester de formule : sur le dérivé de l'isoindoϋnone de formule :The menthyl ester of formula (II) can be obtained by the action of the β-ketoester of formula: on the isoindoϋnone derivative of formula:
La condensation s'effectue en général dans un solvant organique en présence d'une base. Comme solvant organique, on utilise généralement le diméthylformamide, racétonitrile, le diméthylsulfoxyde, les hydrocarbures aromatiques (benzène, toluène) ou la N-méthylpyrrolidone. Comme base, on utilise généralement un carbonate de métal alcalin (sodium, potassium) ou un hydrure tel que l'hydrure de sodium. Généralement, la réaction est mise en oeuvre à une température comprise entre 0 et 50°C.Condensation is generally carried out in an organic solvent in the presence of a base. As organic solvent, dimethylformamide, racetonitrile, dimethyl sulfoxide, aromatic hydrocarbons (benzene, toluene) or N-methylpyrrolidone are generally used. As a base, an alkali metal carbonate (sodium, potassium) or a hydride such as sodium hydride is generally used. Generally, the reaction is carried out at a temperature between 0 and 50 ° C.
Le produit de formule (IV) peut être obtenu par chloruration du produit de formule :The product of formula (IV) can be obtained by chlorination of the product of formula:
On opère généralement en présence d'un agent de chloruration tel que le chlorure de sulfinyle ou lOxychlorure de phosphore en présence de quantités catalytiques de diméthylformamide à une température comprise entre 20°C et la température de reflux du mélange réactionnel.It is generally carried out in the presence of a chlorination agent such as sulfinyl chloride or phosphorus oxychloride in the presence of catalytic amounts of dimethylformamide at a temperature between 20 ° C. and the reflux temperature of the reaction mixture.
Le produit de formule (V) peut être obtenu selon le procédé décrit, par exemple, dans le brevet belge BE 835325. Le β-cétoester de formule (HI) peut être obtenu selon le procédé décrit parThe product of formula (V) can be obtained according to the method described, for example, in Belgian patent BE 835325. The β-ketoester of formula (HI) can be obtained according to the method described by
D.F. Taber et J.C Amedio Jr., J. Org. Chem., 5_Q, 3618 (1985) pour la préparation de β-cétoester par transestérif ication catalysée à la diméthylaminopyridine. L'exemple suivant illustre la présente invention.DF Taber and JC Amedio Jr., J. Org. Chem., 5_Q, 3618 (1985) for the preparation of β-ketoester by dimethylaminopyridine catalyzed transesterification. The following example illustrates the present invention.
E EMP EE EMP E
A une solution de 3,3 g de chloro-3 (chloro-7 naphtyridine-1,8 yl-2)-2 isoindolinone-1 dans 33 cm3 de N-mémylpyrrolidinone, on ajoute, sous agitation, 3,72 g de méthyl-6 oxo-3 heptanoate de menthyle et 3,45 g de carbonate de potassium. La suspension est maintenue pendant 12 heures à une température voisine de 20°C. A la solution obtenue on ajoute 75 cm3 d'eau et on extrait par deux fois 25 cm3 de dichlorométhane. Les extraits organiques réunis sont lavés par 3 fois 50 cm3 d'eau, séchés sur sulfate de magnésium, filtrés et concentrés à sec sous pression réduite (20 kPa) à une température voisine de 40°C. On obtient ainsi 6 g de [(chloro- 7 naphtyridine-1,8 yl-2)-2 oxo-3 isoindolinyl-l]-2 méthyl-6 oxo-3 heptanoate de menthyle dont on sépare l'isomère dextrogyre par chromatographie liquide préparative à haute performance sur colonne Kromasil Si 100 À de 4 x 25 cm en utilisant comme phase mobile le mélange hexane-méthyl tbutyléther (90-10 en volumes) au débit de 100 cm3/minute.To a solution of 3.3 g of chloro-3 (chloro-7 naphthyridin-1.8 yl-2) -2 isoindolinone-1 in 33 cm3 of N-memylpyrrolidinone, 3.72 g of methyl are added with stirring -6 mento oxo-3 heptanoate and 3.45 g of potassium carbonate. The suspension is kept for 12 hours at a temperature in the region of 20 ° C. To the solution obtained is added 75 cm3 of water and extracted twice with 25 cm3 of dichloromethane. The combined organic extracts are washed with 3 times 50 cm3 of water, dried over magnesium sulfate, filtered and concentrated to dryness under reduced pressure (20 kPa) at a temperature in the region of 40 ° C. 6 g of [(chloro-naphthyridine-1,8 yl-2) -2 3-oxo-isoindolinyl-1] -2 methyl-6 oxo-3 menthyl heptanoate are thus obtained from which the dextrorotatory isomer is separated by liquid chromatography high performance preparation on Kromasil Si 100 A column of 4 x 25 cm using as mobile phase the hexane-methyl tbutyl ether mixture (90-10 by volume) at a flow rate of 100 cm3 / minute.
A 5 cm3 d'acide sulfurique à 98 % on ajoute, sous agitation à 0°C, 50 mg de (+)-[(chloro-7 naphtyridine-1,8 yl-2)-2 oxo-3 isoindolinyl-l]-2 méthyl-6 oxo-3 heptanoate de menthyle. {[α]20τ> = + 233,9° (c = 1 ; chlorure de méthylène)}. La solution obtenue est agitée pendant 1 heure à une température voisine de 0°C, puis versée dans 25 g de glace. On extrait la phase aqueuse par deux fois 5 cm3 de dichlorométhane. Les extraits organiques réunis sont lavés par 10 cm3 d'une solution diluée d'ammoniaque (q.s.p. pH = 7), séchés sur sulfate de magnésium, filtrés et concentrés à sec sous pression réduite (20 kPa) à une température voisine de 20°C. On obtient ainsi 32,3 mg de (+)-(chloro-7 naphtyridine-1,8 yl-2)-2 (méthyl-5 oxo-2 hexyl)-3 isoindolinone-1 sous forme d'un solide blanc dont les caractéristiques sont les suivantes :To 5 cm3 of 98% sulfuric acid are added, with stirring at 0 ° C., 50 mg of (+) - [(7-chloro-naphthyridine-1,8 yl-2) -2 oxo-3 isoindolinyl-1] -2 Methyl-6 oxo-3 menthyl heptanoate. {[α] 20τ> = + 233.9 ° (c = 1; methylene chloride)}. The solution obtained is stirred for 1 hour at a temperature in the region of 0 ° C, then poured into 25 g of ice. The aqueous phase is extracted with twice 5 cm 3 of dichloromethane. The combined organic extracts are washed with 10 cm3 of a dilute ammonia solution (qs pH = 7), dried over magnesium sulfate, filtered and concentrated to dryness under reduced pressure (20 kPa) at a temperature in the region of 20 ° C . 32.3 mg of (+) - (7-chloro-naphthyridine-1,8 yl-2) -2 (methyl-5 oxo-2 hexyl) -3 isoindolinone-1 are thus obtained in the form of a white solid, the features are:
- titre énantiomérique : 95 %- enantiomeric titer: 95%
- pouvoir rotatoire : [CC]20D = +123° (c = 1 ; CH2CI2). - rotary power: [CC] 20 D = + 123 ° (c = 1; CH2CI2).

Claims

REVENDICATIONS
1 - Procédé de préparation de l'isomère dextrogyre du produit de formule1 - Process for the preparation of the dextrorotatory isomer of the product of formula
caractérisé en ce que l'on effectue une désalcoxycarbonylation de l'ester de menthyle dextrogyre de formule : characterized in that a dealkoxycarbonylation of the dextrorotatory menthyl ester of formula:
2 - Procédé selon la revendication 1 caractérisé en ce que la désalcoxycarbo¬ nylation est effectuée au moyen d'un acide fort.2 - Process according to claim 1 characterized in that the dealkoxycarbo¬ nylation is carried out by means of a strong acid.
3 - Procédé selon la revendication 2 caractérisé en ce que l'acide fort est l'acide sulfurique.3 - Process according to claim 2 characterized in that the strong acid is sulfuric acid.
4 - Procédé selon l'une des revendications 1 à 3 caractérisé en ce que l'on opère à une température voisine de 0°C. 4 - Method according to one of claims 1 to 3 characterized in that one operates at a temperature close to 0 ° C.
EP92920565A 1991-09-09 1992-09-07 Method for preparing the dextrorotatory isomer of an isoindolinone derivative Ceased EP0603324A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9111101A FR2681068B1 (en) 1991-09-09 1991-09-09 PROCESS FOR THE PREPARATION OF THE DEXTROGYRE ISOMER OF AN ISOINDOLINONE DERIVATIVE.
FR9111101 1991-09-09
PCT/FR1992/000848 WO1993005041A1 (en) 1991-09-09 1992-09-07 Method for preparing the dextrorotatory isomer of an isoindolinone derivative

Publications (1)

Publication Number Publication Date
EP0603324A1 true EP0603324A1 (en) 1994-06-29

Family

ID=9416751

Family Applications (2)

Application Number Title Priority Date Filing Date
EP92920565A Ceased EP0603324A1 (en) 1991-09-09 1992-09-07 Method for preparing the dextrorotatory isomer of an isoindolinone derivative
EP92402442A Pending EP0534814A1 (en) 1991-09-09 1992-09-07 Process for the preparation of a dextrorotatory isomer of isoindoline derivative

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP92402442A Pending EP0534814A1 (en) 1991-09-09 1992-09-07 Process for the preparation of a dextrorotatory isomer of isoindoline derivative

Country Status (6)

Country Link
EP (2) EP0603324A1 (en)
JP (1) JPH07500094A (en)
CA (1) CA2117196A1 (en)
FR (1) FR2681068B1 (en)
MX (1) MX9205115A (en)
WO (1) WO1993005041A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU783516B2 (en) 2001-04-30 2005-11-03 Warner-Lambert Company Methods, kits and compositions for using pyrrole derivatives
DK1490363T3 (en) 2002-03-29 2006-05-15 Indevus Pharmaceuticals Inc Methods for Preparation of 2-7-Chloro-1,8-naphthyridin-2-yl) -3- (5-methyl-2-oxo-hexyl) 1-isoindolinone

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9305041A1 *

Also Published As

Publication number Publication date
MX9205115A (en) 1993-04-01
FR2681068A1 (en) 1993-03-12
CA2117196A1 (en) 1993-03-18
FR2681068B1 (en) 1993-11-19
WO1993005041A1 (en) 1993-03-18
EP0534814A1 (en) 1993-03-31
JPH07500094A (en) 1995-01-05

Similar Documents

Publication Publication Date Title
PL164176B1 (en) Method of producing optically active /2s/- or /2r/-endo-bicyclo [2.2.1] heptan-2-ol
CA2342950C (en) New process for preparing 11-amino-3-chloro-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c,f][1,2]-thia zepine and application in the synthesis of tianeptine
CH616161A5 (en)
EP0603324A1 (en) Method for preparing the dextrorotatory isomer of an isoindolinone derivative
EP0498706A1 (en) Process for the preparation of (-)-(2R,3S)-2,3-epoxy-3-(4-methoxyphenyl)methylpropionate
EA010100B1 (en) Process for the preparation of (4-hydroxy-6-oxo-tetrahydropyran-2-yl) acetonitrile and derivatives thereof
EP0086678A1 (en) Process for the preparation of 2-acyl-1,3,4,6,7,11b-2H-hexahydro-4-pyrazino(2,1-a)isoquinolinones and intermediates
WO1992010461A1 (en) Process for the preparation of derivatives of 3,5-dihydroxy pentanoic acid
EP1140785B1 (en) Method for preparing polyhalogenated paratrifluoromethylanilines
JPH03193770A (en) Preparation of diltiazem intermediate
CA2112981C (en) Process for the preparation of optical isomers of a amino-2 napththyridine derivative
WO1993001188A1 (en) Method for preparing optical isomers of a 2-amino naphthyridine derivative
EP0598765B1 (en) 2-aminonaphthyridine derivative, its preparation and use
WO1993001187A1 (en) Process for the preparation of a dextrogyral isomer of an isoindolinone derivative
EP0561664A1 (en) Process for the preparation of 4-pyrimidines
EP2144866A1 (en) Method for preparing 2-(n-butyl)-5-nitrobenzofuran
FR2766821A1 (en) 1,3-OXAZOLINYL-BIPHENYL DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS SYNTHESIS INTERMEDIATES
EP0647623A1 (en) Intermediates for the preparation of vitamin A and carotenoids and process for their preparation
FR2667600A1 (en) PROCESS FOR THE SYNTHESIS OF MONOHALOGENOALCANOYLFERROCENES
WO1993011125A1 (en) Process for the preparation of a racemic 2-aminonaphthyridine derivative
BE818471A (en) PROCESS FOR PREPARING 1-ARALKYL-4-AMINO-METHYLPIPERIDINE-4-OLS
FR2633622A1 (en) SULFONYL INDOLIZINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS SYNTHESIS INTERMEDIATES
EP0016665B1 (en) Process for the preparation of xanthone derivatives
FR2600649A1 (en) PROCESS FOR THE PREPARATION OF LEVOMEPROMAZINE ACID MALEATE
WO2004103969A1 (en) Novel method for the synthesis of (2s, 3as, 7as)-perhydroindole-2-carboxylic acid and the esters thereof, and application in the synethesis of perindopril

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19940303

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU NL SE

XX Miscellaneous

Free format text: VERBUNDEN MIT 92402442.5/0534814 (EUROPAEISCHE ANMELDENUMMER/VEROEFFENTLICHUNGSNUMMER) DURCH ENTSCHEIDUNG VOM 26.01.95.

17Q First examination report despatched

Effective date: 19950224

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 19950814